Investigations into novel solid forms of the anti-inflammatory drug oxaprozin may lead to a new combined asthma therapy An exploratory study by A*STAR scientists into novel solid forms of the anti-inflammatory drug oxaprozin may lead to improvements for the asthma drug, salbutamol, and help reduce inflammation of the airways. Many drugs, in their original ‘parent’ […]
This post first appeared on Biotechin.asia – Your Daily Biotech And Healthca, please read the originial post: here
